GARY WAYNE COX
OKLAHOMA CITY, OK
Browse related groups: OK Acerta Pharma LLC All categories
This page merges CMS profile IDs: 11305201, 11337503 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$1,595.99
- Category: General Payments
- Program years: PY2021–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $443.19 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $443.19 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $264.03 | 3 |
| Janssen Pharmaceuticals, Inc | $74.69 | 2 |
| BTG INTERNATIONAL, INC. | $61.70 | 1 |
| Lexicon Pharmaceuticals, Inc. | $27.39 | 1 |
| Merck Sharp & Dohme Corporation | $15.38 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078139279 | Janssen Pharmaceuticals, Inc | $54.04 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078139935 | Janssen Pharmaceuticals, Inc | $20.65 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1081723991 | Lexicon Pharmaceuticals, Inc. | $27.39 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104373491 | AstraZeneca Pharmaceuticals LP | $16.52 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104433735 | AstraZeneca Pharmaceuticals LP | $122.83 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105811941 | AstraZeneca Pharmaceuticals LP | $124.68 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126178536 | BTG International, Inc. | $61.70 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141961406 | Merck Sharp & Dohme LLC | $15.38 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11305201, 11337503
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.